Clinical Trial Update: Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating topiramate for treatment of obesity in patients with polycystic ovary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Polycystic Ovary Syndrome

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Obesity, Polycystic Ovary Syndrome | Phase 4 | Status: UNKNOWN